Skip to main content

Table 3 The comparison between the baseline ECW/TBW levels and the fluid response to dapagliflozin

From: The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease

Baseline ECW/TBW

Relative change in the ECW/TBW (%)

Absolute change in the ECW/TBW

Relative change in the ECW (%)

Absolute change in the ECW (L)

Low (< 0.400) [n = 8]

0.3 ± 0.6*

0.001 ± 0.003*

− 1.6 ± 2.8*

− 0.2 ± 0.5*

High (≥ 0.400) [n = 28]

− 1.7 ± 0.3

− 0.007 ± 0.001

− 8.1 ± 1.5

− 1.4 ± 0.3

  1. Values are presented as the mean ± standard error
  2. ECW extracellular water, TBW total body water
  3. *p < 0.05 vs. ECW/TBW over 0.400 of each parameter